Difficulty: Medium
Average Score: 78%
Practice
A commonly encountered risk factor for deep venous thrombosis (DVT) and pulmonary embolism (PE) in the pediatric population is:
Correct answer
A
Rationale
In the pediatric population, antiphospholipid antibody syndrome is a commonly encountered risk factor for deep venous thrombosis (DVT) and pulmonary embolism (PE). This autoimmune disorder leads to an increased risk of blood clots due to the presence of antibodies that target phospholipids in the blood vessel walls, promoting clot formation.
Option A, antiphospholipid antibody syndrome, is the correct answer because it directly predisposes individuals, including children, to thrombotic events. Hematologic malignancies (Option B), although they can increase the risk of thrombosis, are not as commonly associated with DVT and PE in the pediatric population as antiphospholipid antibody syndrome. Sickle cell disease (Option C) is more closely linked to vaso-occlusive crises and acute chest syndrome rather than DVT and PE. Nephrotic syndrome (Option D) can lead to hypercoagulability, but it is not as prevalent a risk factor for DVT and PE in children as antiphospholipid antibody syndrome.
Educationally, understanding the unique risk factors for DVT and PE in pediatric patients is crucial for nurses caring for this population. Recognizing the association between antiphospholipid antibody syndrome and thrombotic events can guide preventative measures and prompt early intervention to reduce the risk of life-threatening complications such as PE. Identifying and addressing these risk factors promptly can significantly improve patient outcomes and quality of care.
Option A, antiphospholipid antibody syndrome, is the correct answer because it directly predisposes individuals, including children, to thrombotic events. Hematologic malignancies (Option B), although they can increase the risk of thrombosis, are not as commonly associated with DVT and PE in the pediatric population as antiphospholipid antibody syndrome. Sickle cell disease (Option C) is more closely linked to vaso-occlusive crises and acute chest syndrome rather than DVT and PE. Nephrotic syndrome (Option D) can lead to hypercoagulability, but it is not as prevalent a risk factor for DVT and PE in children as antiphospholipid antibody syndrome.
Educationally, understanding the unique risk factors for DVT and PE in pediatric patients is crucial for nurses caring for this population. Recognizing the association between antiphospholipid antibody syndrome and thrombotic events can guide preventative measures and prompt early intervention to reduce the risk of life-threatening complications such as PE. Identifying and addressing these risk factors promptly can significantly improve patient outcomes and quality of care.